BLA-DMS Neural Circuit Activation for OCD Animal Model Construction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current OCD animal models fail to reproduce comprehensive obsessive-compulsive behaviors and do not provide insight into the interaction between anxiety and obsessive-compulsive behaviors, limiting their effectiveness in understanding and treating OCD and related disorders.
Innovation Solution
A method is developed to construct an animal model of obsessive-compulsive disorder by activating the neural circuit connecting the basolateral amygdala to the dorsomedial striatum, using physical or chemical activation techniques such as optogenetics or chemogenetics, to induce representative OCD behaviors like checking, repetitive, cleaning, and hoarding behaviors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If specific genes are deleted to construct OCD animal models, then the model construction is straightforward, but the model fails to reproduce comprehensive obsessive-compulsive behaviors
Solution Approach 1:
The patent changes the construction parameter from genetic deletion to neural circuit activation. By activating the BLA-DMS neural circuit through optogenetics or chemogenetics, the model reproduces comprehensive OCD behaviors including checking, repetitive, cleaning, and hoarding behaviors, which genetic deletion models fail to achieve.
2Ease of manufacture
If conventional OCD animal models are used, then the model construction is established, but the interaction between anxiety behavior and OCD is not provided
Solution Approach 1:
The patent introduces the basolateral amygdala (BLA) as an intermediary element that connects anxiety behavior with obsessive-compulsive behavior. The BLA-DMS neural circuit serves as the mediating pathway, allowing the model to reproduce both anxiety-like behaviors and OCD behaviors simultaneously, thereby revealing their interaction mechanism.
3Ease of manufacture
If SSRI-based drugs are used for treatment, then the treatment approach is established, but a significant number of patients are resistant to currently available treatments
Solution Approach 1:
The patent changes the therapeutic target parameter from the serotonin system (SSRI target) to the BLA-DMS neural circuit. By targeting this specific neural circuit through optogenetics, chemogenetics, or pharmacological modulation, the approach aims to overcome SSRI resistance and provide effective treatment for patients who do not respond to conventional serotonin-based therapies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The model effectively reproduces all comprehensive OCD behaviors, providing a new understanding of the interaction between anxiety and obsessive-compulsive behaviors, and can be used for screening candidate drugs for OCD treatment.
Implementation Method 1
using physical or chemical activation techniques such as optogenetics or chemogenetics
Implementation Method 2
using physical or chemical activation techniques such as optogenetics or chemogenetics
Data Source
AI summary
Provided is an obsessive-compulsive disorder animal model and a production method thereof, in which a neuronal circuit connecting the basolateral amygdala (BLA) and the dorsomedial striatum (DMS) is activated. In the present disclosure, it was confirmed that the BLA and DMS are connected to each other, and that when the BLA-DMS neuronal circuit is activated, there is a large increase in checking, repeating, cleaning, and collecting, which are compulsive behaviors representative of obsessive-compulsive disorder, and a decrease in cognitive flexibility. Therefore, animals in which the BLA-DMS neuronal circuit is activated may be useful as animal models for studying obsessive-compulsive disorder. In particular, the obsessive-compulsive disorder animal model can reproduce all of the compulsive behaviors and thus may become the first animal model to provide an understanding of the interactions between anxiety behaviors and compulsive behaviors, which existing animal models have not been able to provide.